share

9-Fluoro-11Beta,17,21-Trihydroxy-16Alpha-Methylpregna-1,4-Diene-3,20-Dione 21-Valerate CAS NO 2600-31-9


Unit Price:

CAS No.:2600-31-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

9-Fluoro-11Beta,17,21-Trihydroxy-16Alpha-Methylpregna-1,4-Diene-3,20-Dione 21-Valerate is a high-purity synthetic corticosteroid derivative, valued for its potent anti-inflammatory and immunosuppressive activity. This compound is a critical pharmaceutical intermediate, essential for the synthesis of advanced topical and systemic corticosteroid medications. It is primarily required by pharmaceutical R&D laboratories, active pharmaceutical ingredient (API) manufacturers, and fine chemical suppliers serving the global healthcare sector.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of potent corticosteroid APIs, such as betamethasone valerate.
  • Topical Corticosteroid Production: Used in manufacturing creams, ointments, and lotions for treating skin conditions like eczema, psoriasis, and dermatitis.
  • Systemic Corticosteroid Development: Serves as a precursor for injectable or oral formulations targeting severe inflammatory and autoimmune disorders.
  • Research & Development: Utilized in pharmacological studies to investigate glucocorticoid receptor activity and develop new anti-inflammatory agents.
  • Veterinary Medicine: Applied in the development of anti-inflammatory treatments for animals.
  • Reference Standard: Serves as an analytical standard for quality control and regulatory testing in pharmaceutical laboratories.

Basic Information

Product Name 9-Fluoro-11Beta,17,21-Trihydroxy-16Alpha-Methylpregna-1,4-Diene-3,20-Dione 21-Valerate
CAS No. 2600-31-9
Molecular Formula C27H37FO6
Molecular Weight 476.58 g/mol
Synonyms Betamethasone 17-Valerate; Betamethasone Valerate; Betnovate; Valisone; 9α-Fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-valerate; Celestoderm-V; Betamethasone 17-Valerate (USP); NSC-39471
EINECS 220-008-8

Quality Control

Our 9-Fluoro-11Beta,17,21-Trihydroxy-16Alpha-Methylpregna-1,4-Diene-3,20-Dione 21-Valerate is manufactured under strict quality management systems. It is produced to meet exacting standards suitable for pharmaceutical intermediate use, with typical purity levels exceeding 98.5% (by HPLC). Each batch is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We ensure compliance with relevant ICH guidelines and can support customer-specific validation requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption. Keep away from incompatible materials.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 98.5%
Related Substances (HPLC) Total impurities ≤ 1.5% Any single impurity ≤ 0.5%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.